ImmunoGen, Inc. (IMGN) — Business segments and KPIs
Revenue by business segment and geography for ImmunoGen, Inc., with year-over-year trends.
FY 2022
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| KADCYLA | 39.00M | 59.8% |
| Initial targets | 18.40M | 28.2% |
| Upfront payment | 7.50M | 11.5% |
| Future Technological Improvements | 300K | 0.5% |